HCMT
AGIO icon

Highland Capital Management (Texas)’s Agios Pharmaceuticals AGIO Stock Holding History

Highland Capital Management (Texas)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-57,323
Closed -$5.41M – 311
2015
Q1 		$5.41M Buy
+57,323
New +$6.42M 0.11% 145

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highland Capital Management (Texas)'s AGIO Position: Q2 2015 in Review

Highland Capital Management (Texas) sold out of Agios Pharmaceuticals (AGIO) in Q2 2015, closing a stake of 57,323 shares — an estimated $5.41M sold.

Highland Capital Management (Texas) first reported a position in AGIO in Q1 2015 and held it in 1 quarter. The position peaked at $5.41M in Q1 2015. 161 funds tracked by Wall St. Rank hold AGIO as of Q2 2015.

  • Highland Capital Management (Texas) reported no remaining Agios Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 57,323 Agios Pharmaceuticals shares in Q2 2015, an estimated $5.41M.
  • Highland Capital Management (Texas) first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Agios Pharmaceuticals position peaked at $5.41M in Q1 2015.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2015, filed 14 Aug 2015.